Page last updated: 2024-12-08
vibo-quercitol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
vibo-quercitol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 441438 |
CHEMBL ID | 37104 |
CHEMBL ID | 3351099 |
CHEBI ID | 37600 |
SCHEMBL ID | 5151166 |
SCHEMBL ID | 17925160 |
MeSH ID | M0508929 |
Synonyms (24)
Synonym |
---|
1-d-3-deoxy-myo-inositol |
CHEBI:37600 , |
1l-1,2,4/3,5-cyclohexanepentol |
d-1-deoxy-myo-inositol |
(1r,2r,3r,4s,5r)-cyclohexane-1,2,3,4,5-pentol |
488-76-6 |
(-)-viburnitol |
C08259 |
Q0069 |
(-)-vibo-quercitol |
CHEMBL37104 |
(1r,2r,4s,5r)-cyclohexane-1,2,3,4,5-pentol |
(1r,2s,4r,5r)-cyclohexane-1,2,3,4,5-pentol |
SCHEMBL5151166 |
vibo-quercitol |
W-202865 |
DTXSID10331579 |
l-chiro-inositol, 1-deoxy- |
CHEMBL3351099 |
SCHEMBL17925160 |
(1r,2r,3r,4s,5r)-cyclohexane-1,2,3,4,5-pentaol |
FS-9928 |
Q27104416 |
AKOS040755970 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (1)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID74520 | Inhibitory activity against Glucosylceramidase in mouse liver; Significant activity | 1999 | Bioorganic & medicinal chemistry letters, Jun-07, Volume: 9, Issue:11 | Synthesis and evaluation of glucocerebrosidase inhibitory activity of anhydro deoxyinositols from (+)-epi- and (-)-vibo-quercitols. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 13.13
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.13) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (16.67%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (83.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |